ACTIVE STUDIES RECRUITING: • 20220196 (MARITIME-CV) – Cardiovascular Disease / Obesity(a) A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity. Those meeting the eligibility criteria will receive trial-related procedures [...]
We are a specialized clinical research company that conducts trials on behalf of our partners in the fields of endocrinology, diabetes, cardiovascular disease, renal disease, and beyond.
PlanIt Research is affiliated with the Endocrine Center of Houston.
CONTACT INFORMATION
10837 Katy Frwy, #200
Houston, TX 77079
713-973-3418
713-973-3415
info@PlanItResearch.com
© Copyright 2023 PlanIt Research | All Rights ReservedDecember 7, 2025